JAMP Digoxin recall in Canada: incorrect dosage
In plain language
This recall involves JAMP Digoxin 0.0625 mg and 0.125 mg tablets sold in Canada. It's being recalled because some tablets may be overweight or underweight, leading to an incorrect dose. Continue taking the medication and speak with your pharmacist as soon as possible.
What to do
- Speak with your pharmacist as soon as possible.
- Your pharmacist will check if your product is affected and provide a replacement.
- Continue taking your JAMP Digoxin tablets until you speak with your pharmacist.
- Contact a healthcare professional immediately if you experience serious side effects.
- Contact JAMP Pharma Corporation with questions.
Get alerts for recalls like this
Get email alerts when new recalls affect products in this category.
Affected products
JAMP DIGOXIN 0.125 MG
Lot: EG23DGY001, EG23DGY002
JAMP DIGOXIN 0.0625 MG
Lot: EG24DGX001
Why this matters
Incorrect dosage due to overweight or underweight tablets
Do I have this product?
This recall only applies to specific products. Follow the steps below to check.
- 1
Check the product name
Make sure your product name matches one of the affected products listed above.
- 2
Check the lot number
Lot numbers identify specific production batches.
Affected lots: EG23DGY001, EG23DGY002, EG24DGX001
If your product matches one or more of the details above, it may be affected by this recall.
If your product does not match these details, it is not affected by this recall.
When in doubt, always check the official notice.
Frequently Asked Questions
Why was this product recalled?
Incorrect dosage due to overweight or underweight tablets
What should consumers do?
Speak with your pharmacist as soon as possible. Your pharmacist will check if your product is affected and provide a replacement. Continue taking your JAMP Digoxin tablets until you speak with your pharmacist. Contact a healthcare professional immediately if you experience serious side effects. Contact JAMP Pharma Corporation with questions.
Where was the product sold?
This product was sold in Canada. For specific retailers or distribution areas, please check the official recall notice linked on this page.
Is there a health risk?
Yes, there may be a health risk. Incorrect dosage due to overweight or underweight tablets
When was this product recalled?
This product was recalled on August 6, 2024.
Is the JAMP brand affected by this recall?
Yes, JAMP products are affected by this recall. This recall involves JAMP Digoxin 0.0625 mg and 0.125 mg tablets sold in Canada. It's being recalled because some tablets may be overweight or underweight, leading to an incorrect dose. Continue taking the medication and speak with your pharmacist as soon as possible.